NDC 72205-070 – Glycopyrrolate
Glycopyrrolate 1 mg/5mL · Liquid · Oral
Product NDC72205-070
Product details
- Brand name
- Glycopyrrolate
- Generic name
- Glycopyrrolate
- Labeler
- Novadoz Pharmaceuticals LLC
- Dosage form
- Liquid
- Route
- Oral
- Marketing category
- ANDA · ANDA216084
- Marketed since
- April 8, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anticholinergic; Cholinergic Muscarinic Antagonist
Active ingredients
- Glycopyrrolate 1 mg/5mL
Uses, dosage, side effects and warnings for Glycopyrrolate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 72205-070-72 | 1 BOTTLE in 1 CARTON (72205-070-72) / 473 mL in 1 BOTTLE | Jun 1, 2025 |
Recalls mentioning this NDC
- D-0300-2026 Feb 4, 2026 · Class III
Failed Impurities/Degradation Specifications
Other Glycopyrrolate products
- 16729-471 Glycopyrrolate .2 mg/mL · Injection · Accord Healthcare, Inc.,
- 16729-472 Glycopyrrolate .2 mg/mL · Injection · Accord Healthcare, Inc.,
- 16729-473 Glycopyrrolate .2 mg/mL · Injection · Accord Healthcare, Inc.,
- 16729-474 Glycopyrrolate .2 mg/mL · Injection · Accord Healthcare, Inc.,
- 15955-318 Glycopyrrolate 2 mg/1 · Tablet · Alembic Labs LLC
- 15955-305 Glycopyrrolate 1 mg/1 · Tablet · Alembic Labs LLC
- 62332-607 Glycopyrrolate .2 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 62332-629 Glycopyrrolate .2 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 62332-628 Glycopyrrolate .2 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 62332-627 Glycopyrrolate .2 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 60687-458 Glycopyrrolate 1 mg/1 · Tablet · American Health Packaging
- 0517-4601 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.